All companies › ONMD

ONMD · OneMedNet Corp

Everything on this page is public record — SEC Form 4 filings and congressional disclosures — alongside any INSIDER SCANNER research case for this company.

Open-market buys0
Open-market sells5
Research cases0
Last filing2026-09-24

Insider flow: Selling only — a count of disclosed transactions, not a rating or a recommendation.

Insider transaction timeline

Every reported transaction, positioned by trade date. Purchases sit above the axis, sales below; circle area is proportional to dollar value. No share-price line is drawn — this feed carries transaction prices only, and a price history inferred from them would imply market data the filings do not contain.

Open-market purchase Open-market sale
2026-09-14 — Golden Robert Lawrence · sold 2,500 @ $6.60 2026-09-15 — Golden Robert Lawrence · sold 3,000 @ $6.30 2026-09-21 — Golden Robert Lawrence · sold 3,000 @ $6.63 2026-09-22 — Green Aaron · sold 5,000 @ $7.39 2026-09-24 — Green Aaron · sold 1,667 @ $6.48
2026-09-142026-09-24

Insider participation

One row per insider, one cell per reported transaction, shaded by value. Repeat buying and activity clustered in time are visible at a glance.

Golden Robert Lawrence Chief Financial Officer, Director
Green Aaron Chief Executive Officer, Director
Included with a free account

The analysis built on top of these filings

The filings above are public record and stay public here. What an account adds for $ONMD is the reading of them — and for this company, that is what the list below says it is, no more.

  • Transaction timelineThe [{'transaction_date': '2026-09-24', 'insider_name': 'Green Aaron', 'insider_title': 'Chief Executive Officer, Director', 'transaction_type': 'Open-market sell', 'shares': 1667.0, 'price': 6.48, 'value': 10802.16, 'is_buy': False}, {'transaction_date': '2026-09-22', 'insider_name': 'Green Aaron', 'insider_title': 'Chief Executive Officer, Director', 'transaction_type': 'Open-market sell', 'shares': 5000.0, 'price': 7.392, 'value': 36960.0, 'is_buy': False}, {'transaction_date': '2026-09-21', 'insider_name': 'Golden Robert Lawrence', 'insider_title': 'Chief Financial Officer, Director', 'transaction_type': 'Open-market sell', 'shares': 3000.0, 'price': 6.63, 'value': 19890.0, 'is_buy': False}, {'transaction_date': '2026-09-15', 'insider_name': 'Golden Robert Lawrence', 'insider_title': 'Chief Financial Officer, Director', 'transaction_type': 'Open-market sell', 'shares': 3000.0, 'price': 6.3, 'value': 18900.0, 'is_buy': False}, {'transaction_date': '2026-09-14', 'insider_name': 'Golden Robert Lawrence', 'insider_title': 'Chief Financial Officer, Director', 'transaction_type': 'Open-market sell', 'shares': 2500.0, 'price': 6.6, 'value': 16500.0, 'is_buy': False}] reported transactions plotted over the window rather than listed, so concentration is visible.

Not available for ONMD today: no reported open-market purchases in this window, so there is no insider cost basis to compute; no research case — nothing here has cleared the scoring threshold. Both appear on this page on their own if that changes.

A free account opens all of it.

Not financial advice. This page reports public filings and past research output. It is not a recommendation to buy or sell, and no price target here is a prediction. Trade at your own risk.